A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants

NCT03286751 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY900014
DRUG: Insulin Lispro

Sponsor

Eli Lilly and Company